Olprinone

Olprinone
Clinical data
Routes of; administration	IV
Legal status
Legal status	Rx-only (JP). Not marketed in US and the EU;
Identifiers
	IUPAC name 5-imidazo[1,2-a]pyridin-6-yl-6-methyl-2-oxo-1H-pyridine-3-carbonitrile;
CAS Number	106730-54-5 ;
PubChem CID	4593;
ChemSpider	4432 ;
UNII	4Y8BMI9YGC;
CompTox Dashboard (EPA)	DTXSID1048461 ;
Chemical and physical data
Formula	C14H10N4O
Molar mass	250.25 g/mol g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC1=C(C=C(C(=O)N1)C#N)C2=CN3C=CN=C3C=C2;
	InChI InChI=1S/C14H10N4O/c1-9-12(6-11(7-15)14(19)17-9)10-2-3-13-16-4-5-18(13)8-10/h2-6,8H,1H3,(H,17,19) ; Key:JPAWFIIYTJQOKW-UHFFFAOYSA-N ;
	(what is this?) (verify)

Olprinone (INN) is a cardiotonic agent.^[1] It has been marketed in Japan since 1996.^[2]

References

^ Uemura Y, Tanaka S, Ida S, Yuzuriha T (December 1993). "Pharmacokinetic study of loprinone hydrochloride, a new cardiotonic agent, in beagle dogs". J. Pharm. Pharmacol. 45 (12): 1077–81. doi:10.1111/j.2042-7158.1993.tb07184.x. PMID 7908977.
^ Template:En icon"Coretec Injection 5 mg" (PDF). Eisai Co. April 2005. Retrieved 2008-06-26. ^{[dead link]}

This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.